2020-07-10 · Die Arcus Biosciences Inc Registered Shs Aktie wird unter der ISIN US03969F1093 an den Börsen New York, NYSE MKT, Bats und NDN gehandelt.
Arcus Biosciences Aktie WKN DE: A2JGDZ / ISIN: US03969F1093. 37,07 USD: 1,77 USD: 5,01 % 21:15:00 NYSE: Arcus Biosciences Aktie [WKN DE: A2JGDZ / ISIN: US03969F1093] Kaufen. Verkaufen Kurse + Charts + Realtime News + Analysen Fundamental Unternehmen
Hela positionen avyttras med en Köp aktien Avid Bioservices, Inc. - % Series E Convertible Preferred 1/7 ARCUS BIOSCIENCES INC COM RCUS 16/1 ARDAGH GROUP SA P/E-tal, -0,08. P/S-tal, 0,78. Kapital per aktie (SEK), 0,26, 0,22, -0,25. Senast betalkurs/eget kapital (SEK), -2,42. Direktavkastning (%). Utdelning per aktie (SEK).
-0.31. -0.60. -0.97. -1.60. Aktier.
Hos Nordnet kan du handle fra 0 kr.
Få de seneste nyheder, og læs mere om Arcus Biosciences, Inc.(RCUS)
Gileads andel af Arcus er dermed løftet til 19,5 pct. fra tidligere 13 pct.
Experts in antigen design and hybridoma development. Proven experience with protein expression, purification and analytics. Proven track record for a broad range of in vitro and in vivo models of disease. Our accomplished team delivers royalty-free cell lines for even the most challenging proteins.
28.03. A2DL9L.
, April 08, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will report first quarter 2021 financial results on Thursday,
The estimated Net Worth of Kathryn E Falberg is at least $38.8 Million dollars as of 19 November 2020. Ms. Falberg owns over 20,000 units of UroGen Pharma Ltd stock worth over $51,605 and over the last 13 years she sold URGN stock worth over $38,412,002.
Hvad betyder nettopris
-1.60.
Hos Avanza kan du handla svenska aktier för upp till 50 000 SEK
Arcus Biosciences Inc är en aktie för Arcus Biosciences Inc med ISIN-beteckning US03969F1093.
Skatt på lotteri vinst
Find the latest Fate Therapeutics, Inc. (FATE) stock quote, history, news and other vital information to help you with your stock trading and investing.
Arcus currently has four molecules in clinical development: Etrumadenant (AB928), the first and Gileads andel af Arcus er dermed løftet til 19,5 pct. fra tidligere 13 pct. Denne gang har det kostet Gilead 39 dollar per aktie, hvilket er 12,3 pct.
Arcus Biosciences Announces Third Quarter 2020 Financial Results and Corporate Updates 11/5/2020 - Commenced 10-year highly strategic partnership with Gilead to deliver next-generation cancer therapies - Recently announced collaboration with AstraZeneca for registrational trial, PACIFIC-8, further validates domvanalimab’s therapeutic potential
2021-02-02 · Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that Gilead Sciences is increasing its 2021-03-06 · A free inside look at Arcus Biosciences salary trends based on 22 salaries wages for 14 jobs at Arcus Biosciences. Salaries posted anonymously by Arcus Biosciences employees. 2021-04-09 · Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, 2021-03-02 · ARCUS BIOSCIENCES INC. (A2JGDZ | US03969F1093) mit aktuellem Aktienkurs, Charts, News und Analysen.
Köp aktien Arcus Biosciences, Inc. (RCUS). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid Aktieägare i de relaterade bolagen äger också aktier i Arcus. Andelen 16 % anger hur många av Altia Oyj-ägarna som även har Arcus i sin portfölj. Informationen bygger på dagsaktuellt ägande hos Avanzas kunder och presenteras för bolag som ägs av minst 100 kunder. Arcus Biosciences Inc är en aktie noterad som RCUS, som inte betalar utdelning. Dess ISIN-kod är US03969F1093.